Page last updated: 2024-10-31

methyl methanesulfonate and Leukemia

methyl methanesulfonate has been researched along with Leukemia in 1 studies

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research Excerpts

ExcerptRelevanceReference
"The effective dose (ED) is the pharmaceutical dosage required to produce a therapeutic response in a fixed proportion of the patients."1.40A random set approach to confidence regions with applications to the effective dose with combinations of agents. ( Jankowski, H; Ji, X; Stanberry, L, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jankowski, H1
Ji, X1
Stanberry, L1

Other Studies

1 other study available for methyl methanesulfonate and Leukemia

ArticleYear
A random set approach to confidence regions with applications to the effective dose with combinations of agents.
    Statistics in medicine, 2014, Oct-30, Volume: 33, Issue:24

    Topics: Algorithms; Animals; Computer Simulation; Confidence Intervals; Decompression Sickness; HL-60 Cells;

2014
chemdatabank.com